Airox Technologies Ltd. IPO Details
Airox Technologies was incorporated on September 26, 2012. The company is a provider of PSA oxygen generators and is among the pioneers to facilitate the penetration of on-premise PSA oxygen generators in Indian hospitals with nearly 872 installed and operational PSA oxygen generators, as of March 31, 2022.
| Bidding Dates |
|---|
| To Be Announced |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price Band | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 0 | - | - | ₹7,500.0 M | DRHP DOC |
Airox Technologies Ltd. issue details
Airox Technologies Ltd. IPO issue size is ₹ 7,500.0 M
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 10% | 15% | 75% |
Airox Technologies Ltd. IMPORTANT IPO DATES
| Issue Open Date | - |
| Issue close Date | - |
| Allotment Date | - |
| Refund Date | - |
| Demat Account Credit Date | - |
| Listing Date | - |
| Listing on Exchange(s) | NSE and BSE |
Airox Technologies Ltd. NUMBER OF SHARES ON OFFER
Airox Technologies Ltd. FINANCIALS
| Period | Net Profit (Rs in millions) | Revenue from Operations (Rs in millions) | Cash Flow from Operations (Rs in millions) | Free Cash Flow (Rs in millions) | Margins |
| FY22 | 900.4 | 2,266.0 | 651.5 | 567.3 | 54.1% |
| FY21 | 158.7 | 729.9 | 65.6 | 65.1 | 32.2% |
| FY20 | 7.6 | 171.3 | 22.8 | 17.8 | 12.4% |
Airox Technologies Ltd. INFORMATION ON IPO ISSUE
About Airox Technologies Ltd.
Airox Technologies was incorporated on September 26, 2012. The company is a provider of PSA oxygen generators and is among the pioneers to facilitate the penetration of on-premise PSA oxygen generators in Indian hospitals with nearly 872 installed and operational PSA oxygen generators, as of March 31, 2022.
Object of the Issue
- To carry out the offer for sale of equity shares aggregating up to Rs 750 crore by the promoter selling shareholders
- To achieve the benefits of listing the equity shares on the stock exchanges
Airox Technologies Ltd. Strengths
Leading providers of PSA oxygen generator
The company is one of the leading players among the PSA oxygen generator providers in terms of operating income, as of Fiscal 2021
Strong and growing customer base
As of March 31, 2022, the company had supplied PSA oxygen generators to 872 customers, which includes 72 PSA oxygen generators to Central Medical Services Society and 34 PSA oxygen generators to other international agencies
Modern and automated manufacturing facility
The company has a modern and automated manufacturing facility with dedicated research and development team
Airox Technologies Ltd. Risks
Covid-19 pandemic
The outbreak of COVID-19 led to an increase in awareness and demand of products and an increase in revenue demand for products or the future impact of the COVID-19 pandemic on business, operating results, cash flows and/or financial condition is uncertain
Dependent on a strategic partner
The company is dependent on a strategic partner for the supply of molecular sieves and vessels and any fluctuations in the price, availability and quality of the raw materials could cause delay and increase costs which may have an adverse effect on our business and operations
IPO FAQs
The category allocation of qualified institutional buyers is 75.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 10.0%.